The use of dexrazoxane in CAYA cancer to prevent cardiovascular toxicity - News Summed Up

The use of dexrazoxane in CAYA cancer to prevent cardiovascular toxicity


Lifestyle education remains a mainstay against modifiable risk factors for survivors of CAYA cancer for their ongoing sustained cardiovascular health. Long-term surveillanceCardiovascular complications are the second leading cause of death in paediatric cancer survivors, second only to secondary malignancies. Alongside prevention, long-term follow-up strategies, early initiation of treatment, and lifestyle modification is essential to maximising cardiovascular outcomes in CAYA cancer survivors. Cardiovascular morbidity in long-term survivors of early-onset cancer: A population-based study. Ellison LF, Xie L, Sung L. Trends in paediatric cancer survival in Canada, 1992 to 2017.


Source: Irish Independent April 06, 2026 13:34 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */